Sarah Joanne Williams

CIK: 0002108922

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ANTX

AN2 Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ANTX
AN2 Therapeutics, Inc.
Sep 1, 2026
Sale(S)
Direct
272 shares at avg. $5.53$2K
ANTX
AN2 Therapeutics, Inc.
May 29, 2026
Sale(S)
Direct
265 shares at avg. $4.43$1K
ANTX
AN2 Therapeutics, Inc.
Mar 3, 2026
Sale(S)
Direct
327 shares at avg. $1.06$346.62
ANTX
AN2 Therapeutics, Inc.
Feb 20, 2026
Award(A)
Direct
48.4K shares-

		Type	Shares	Price		Ownership
Sep 1, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	272	$5.53	$1,504	Direct
May 29, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	265	$4.43	$1,174	Direct
Mar 3, 2026	ANTX AN2 Therapeutics, Inc.	Sale(S)	327	$1.06	$347	Direct
Feb 20, 2026	ANTX AN2 Therapeutics, Inc.	Award(A)	48,375	-	$0	Direct

1-4 of 4 transactions

About Williams Sarah Joanne

Williams Sarah Joanne (SEC CIK 0002108922) files insider reports with the SEC as Principal Accounting Officer of AN2 Therapeutics, Inc. (ANTX).

Signal8 holds 5 ownership filings by Williams Sarah Joanne (1 Form 3, 4 Form 4), filed between Feb 3, 2026 and Sep 4, 2026. Those filings report 4 transactions, from Feb 20, 2026 to Sep 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Williams Sarah Joanne's filings is in MENLO PARK, CA.

Recent filings by Williams Sarah Joanne

Sep 1, 2026: Open-market sale of ANTX shares (Form 4, code S).
May 29, 2026: Open-market sale of ANTX shares (Form 4, code S).
Mar 3, 2026: Open-market sale of ANTX shares (Form 4, code S).
Feb 20, 2026: Grant or award of ANTX shares (Form 4, code A).

Other insiders filing for AN2 Therapeutics, Inc. (ANTX)

Marks Gilbert Lynn, Director
Martin Patricia A., Director
Aziz Kabeer, Director
Trenor Cameron C. III, Chief Medical Officer
Readnour Robin Shane, Director
FitzPatrick Margaret M, Director

How to read Form 4 transaction codes